LumaCyte
Keswick
About LumaCyte
LumaCyte provides researchers with a diagnostic tool that accelerates medical discoveries through a novel approach to cell analysis and sorting. Its patented technology empowers researchers to ask questions and seek answers without the bias of antibody-based diagnostics. Its technology is intended to significantly broaden the horizons of medical research and shorten the time to powerful medical breakthroughs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.8M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2023)
- Website: lumacyte.com
- Phone: +1 888 472 9295
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/lumacyte-175997 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.